Quantcast
Home > Quotes > IDXG

Interpace Diagnostics Group, Inc. Common Stock (IDXG) Quote & Summary Data

IDXG 
$0.751
*  
0.019
2.47%
Get IDXG Alerts
*Delayed - data as of Aug. 22, 2019  -  Find a broker to begin trading IDXG now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    IDXG Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
2.55
Today's High / Low
$ 0.7997 / $ 0.73
Share Volume
127,512
50 Day Avg. Daily Volume
268,622
Previous Close
$ 0.77
52 Week High / Low
$ 1.78 / $ 0.6727
Market Cap
28,685,225
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.7

Intraday Chart

Shares Traded

Share Volume:
127,512
50 Day Avg. Daily Volume:
268,622

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.49

Trading Range

The current last sale of $0.751 is 11.64% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.7997 $ 1.78
 Low: $ 0.73 $ 0.6727

Company Description (as filed with the SEC)

We are a fully integrated commercial and bioinformatics company that develops and provides clinically useful molecular diagnostic tests and pathology services. We develop and commercialize genomic tests and related first line assays principally focused on early detection of patients at high risk of cancer using the latest technology to help personalized medicine and improve patient diagnosis and management. Our tests and services provide mutational analysis of genomic material contained in suspicious cysts, nodules and lesions with the goal of better informing treatment decisions in patients at risk of thyroid, pancreatic, and other cancers. The molecular diagnostic tests we offer enable healthcare providers to better assess cancer risk, helping to avoid unnecessary surgical treatment in patients at low risk.  ... More ...  



Risk Grade

Where does IDXG fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.7501
Open Date:
Aug. 22, 2019
Close Price:
$ 0.751
Close Date:
Aug. 22, 2019


Consensus Recommendation

Analyst Info